|
| U.S. Brand
Names |
|
| Kaon®; K-G® |

|
|
| Generic
Available |
|
|
Yes |

|
|
| Pharmacological Index |
|
|
Electrolyte Supplement, Oral |

|
|
| Use |
|
|
Treatment or prevention of hypokalemia |

|
|
| Pregnancy Risk
Factor |
|
|
A |

|
|
| Contraindications |
|
|
Severe renal impairment, untreated Addison's disease, heat cramps,
hyperkalemia, severe tissue trauma; solid oral dosage forms are contraindicated
in patients in whom there is a structural, pathological, and/or pharmacologic
cause for delay or arrest in passage through the GI tract; an oral liquid
potassium preparation should be used in patients with esophageal compression or
delayed gastric emptying time |

|
|
| Warnings/Precautions |
|
|
Use with caution in patients with cardiac disease, severe renal impairment,
hyperkalemia; patients must be on a cardiac monitor during intermittent
infusions |

|
|
| Adverse
Reactions |
|
|
>10%: Gastrointestinal: Diarrhea, nausea, stomach pain, flatulence,
vomiting (oral)
1% to 10%:
Cardiovascular: Bradycardia
Endocrine & metabolic: Hyperkalemia
Neuromuscular & skeletal: Weakness
Respiratory: Dyspnea
<1%: Chest pain, mental confusion, alkalosis, throat pain, phlebitis,
paresthesias, paralysis |

|
|
| Overdosage/Toxicology |
|
|
Symptoms of overdose include muscle weakness, paralysis, peaked T waves,
flattened P waves, prolongation of QRS complex, ventricular arrhythmias
Removal of potassium can be accomplished by various means; removal through
the GI tract with Kayexalate® administration; by way of
the kidney through diuresis, mineralocorticoid administration or increased
sodium intake; by hemodialysis or peritoneal dialysis; or by shifting potassium
back into the cells by insulin, glucose infusion, or sodium bicarbonate; calcium
chloride reverses cardiac effects |

|
|
| Drug
Interactions |
|
|
Increased effect/levels with potassium-sparing diuretics, salt substitutes,
ACE inhibitors; increased effect of digitalis |

|
|
| Stability |
|
|
Store at room temperature, protect from freezing; use only clear
solutions |

|
|
| Mechanism of
Action |
|
|
Potassium is the major cation of intracellular fluid and is essential for the
conduction of nerve impulses in heart, brain, and skeletal muscle; contraction
of cardiac, skeletal and smooth muscles; maintenance of normal renal function,
acid-base balance, carbohydrate metabolism, and gastric
secretion |

|
|
| Pharmacodynamics/Kinetics |
|
|
Absorption: Absorbed well from upper GI tract
Distribution: Enters cells via active transport from extracellular fluid
Elimination: Largely by the kidneys, but also small amount via the skin and
feces, with most intestinal potassium being reabsorbed |

|
|
| Usual Dosage |
|
|
Oral (doses listed as mEq of potassium):
Children: 2-3 mEq/kg/day
Adults: 40-80 mEq/day
Prevention of hypokalemia during diuretic therapy:
Children: 1-2 mEq/kg/day in 1-2 divided doses
Adults: 16-24 mEq/day in 1-2 divided doses
Treatment of hypokalemia:
Children: 2-5 mEq/kg/day in 2-4 divided doses
Adults: 40-100 mEq/day in 2-4 divided doses |

|
|
| Administration |
|
|
Liquid potassium preparation should be used in patients with esophageal
compression or delayed gastric-emptying time |

|
|
| Monitoring
Parameters |
|
|
Serum potassium, chloride, glucose, pH, urine output (if
indicated) |

|
|
| Test
Interactions |
|
|
ammonia
(B)
|

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
Take with food, water, or fruit juice; swallow tablets whole; do not crush or
chew |

|
|
| Nursing
Implications |
|
|
Do not administer liquid full strength, must be diluted in 2-6 parts of water
or juice |

|
|
| Dosage Forms |
|
|
Elixir: 20 mEq/15 mL
K-G®, Kaon®,
Kaylixir®: 20 mEq/15 mL
Tablet:
Glu-K®: 2 mEq
Kaon®: 5 mEq
|

|
|
Copyright © 2007 Drugs Area
|